Literature DB >> 30793155

A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?

Valérie Marcil1,2, Emile Levy2, Devendra Amre3, Alain Bitton1, Ana Maria Guilhon de Araújo Sant'Anna1, Andrew Szilagy1, Daniel Sinnett3, Ernest G Seidman1.   

Abstract

BACKGROUND: Malnutrition, commonly observed in inflammatory bowel disease (IBD), is associated with increased morbidity and mortality and is attributed to multiple causes. The added energy costs of growth in the child and adolescent with IBD are an additional risk factor.
METHODS: The aim of the study was to perform a cross-sectional comparison of nutritional parameters in IBD between pediatric and adult cases.
RESULTS: We found that prevalence of undernutrition (low body mass index) and hypoalbuminemia was not different in pediatric, compared with adult patients. Anemia and iron deficiency were more often observed in pediatric subjects, compared with adults (59.1% vs 36.9%, respectively, P < 0.0001; and 37.9% vs 25.3%, P < 0.002). Vitamin B12 deficiency was significantly less common in the pediatric than in the adult group (5.4% vs 19.4%, P < 0.0001). Elevated C-reactive protein was more frequent in pediatric compared with adult cases (49.8% vs 38.4%, P < 0.01).
CONCLUSIONS: Patients with active Crohn's disease were more likely to be undernourished in both pediatric and adult populations. In both groups, predicators of undernutrition included low albumin levels (odds ratio [OR], 2.53; P < 0.006) and active disease (OR, 1.99; P < 0.03). Our results call for close surveillance of nutritional status for IBD patients, regardless of age.
© 2019 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; anemia; inflammatory bowel disease; malnutrition; ulcerative colitis

Year:  2019        PMID: 30793155      PMCID: PMC6635818          DOI: 10.1093/ibd/izy403

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  80 in total

Review 1.  Surrogate nutrition markers, malnutrition, and adequacy of nutrition support.

Authors:  David S Seres
Journal:  Nutr Clin Pract       Date:  2005-06       Impact factor: 3.080

2.  Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission.

Authors:  B J Geerling; A Badart-Smook; R W Stockbrügger; R J Brummer
Journal:  Am J Clin Nutr       Date:  1998-05       Impact factor: 7.045

Review 3.  Nutritional therapy in Crohn's disease.

Authors:  M A O'Sullivan; C A O'Morain
Journal:  Inflamm Bowel Dis       Date:  1998-02       Impact factor: 5.325

4.  Vitamin B12 deficiency in inflammatory bowel disease: a prospective observational pilot study.

Authors:  Robert Battat; Uri Kopylov; Joshua Byer; Maida J Sewitch; Elham Rahme; Hacene Nedjar; Elana Zelikovic; Serge Dionne; Talat Bessissow; Waqqas Afif; Paula J Waters; Ernest Seidman; Alain Bitton
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-12       Impact factor: 2.566

5.  Adequacy of nutritional intake in a Canadian population of patients with Crohn's disease.

Authors:  Elaheh Aghdassi; Barbara E Wendland; Melanie Stapleton; Maitreyi Raman; Johane P Allard
Journal:  J Am Diet Assoc       Date:  2007-09

6.  C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.

Authors:  M Henriksen; J Jahnsen; I Lygren; N Stray; J Sauar; M H Vatn; B Moum
Journal:  Gut       Date:  2008-06-19       Impact factor: 23.059

7.  Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency.

Authors:  C Gasché; W Reinisch; H Lochs; B Parsaei; S Bakos; J Wyatt; G F Fueger; A Gangl
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

8.  Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital.

Authors:  Margrit Ebinger; Reiner Leidl; Stefanie Thomas; Christian Von Tirpitz; Max Reinshagen; Guido Adler; Hans-Helmut Konig
Journal:  J Gastroenterol Hepatol       Date:  2004-02       Impact factor: 4.029

9.  Prevalence of and risk factors for vitamin B(12) deficiency in patients with Crohn's disease.

Authors:  Peggy D Headstrom; Stephen J Rulyak; Scott D Lee
Journal:  Inflamm Bowel Dis       Date:  2008-02       Impact factor: 5.325

Review 10.  Vitamin B12 deficiency in inflammatory bowel disease: prevalence, risk factors, evaluation, and management.

Authors:  Robert Battat; Uri Kopylov; Andrew Szilagyi; Anjali Saxena; David S Rosenblatt; Margaret Warner; Talat Bessissow; Ernest Seidman; Alain Bitton
Journal:  Inflamm Bowel Dis       Date:  2014-06       Impact factor: 5.325

View more
  4 in total

Review 1.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

2.  Prevalence and Clinician Recognition of Avoidant/Restrictive Food Intake Disorder in Patients With Inflammatory Bowel Disease.

Authors:  Kimberly Robelin; Peter Senada; Hassan Ghoz; Leslie Sim; Jocelyn Lebow; Michael Picco; John Cangemi; Francis A Farraye; Monia Werlang
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-11

3.  National Trends in Hospitalization, Surgical Resection, and Comorbidities in Pediatric Inflammatory Bowel Disease in the United States, 2002-2015.

Authors:  Faith D Ihekweazu; Deepa Dongarwar; Hamisu M Salihu; Richard Kellermayer
Journal:  Int J MCH AIDS       Date:  2022-03-06

Review 4.  A Vicious Cycle of Osteosarcopeniain Inflammatory Bowel Diseases-Aetiology, Clinical Implications and Therapeutic Perspectives.

Authors:  Dorota Skrzypczak; Alicja Ewa Ratajczak; Aleksandra Szymczak-Tomczak; Agnieszka Dobrowolska; Piotr Eder; Iwona Krela-Kaźmierczak
Journal:  Nutrients       Date:  2021-01-20       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.